A potential U.S. launch of this Chinese biotech's new lung cancer drug - which bested Merck's blockbuster Keytruda - is a key ...

The hitch in decision-making has resulted in a growing backlog of deals at Goldman Sachs, he said ... trading during the market swings around DeepSeek's impact on Nvidia Corp. (NVDA), as well ...

(Bloomberg) — Strategists at Goldman Sachs Group Inc. (GS) cut their targets for key Chinese stock indexes for a second time ...

Goldman Sachs has once again lowered its targets for major Chinese stock indexes, citing growing trade tensions between the U ...